Naloxone dispensing & opioid-overdose mortality
Do regional differences in the association hold up across statistical models?
A question from a screen
Watching Dopesick drew me toward the opioid crisis and the policy trade-offs behind it. Hospital fieldwork and a medical-equipment internship had already made me interested in what happens when systems meet people. This project brought that question into data.
Abstract
Background/Objective: This ecological study examined whether regional differences in pharmacy naloxone dispensing–mortality associations were consistently supported across longitudinal analyses of U.S. states during 2012–2023.
Methods: The panel covered 50 states and the District of Columbia, with 610 available mortality outcomes among 612 potential state-years. State and year fixed-effects models assessed within-state regional associations. Random-intercept and generalized estimating equation (GEE) models included dispensing × region interactions and year effects. Fixed-effects and mixed models used state-cluster CR2 inference. Socioeconomic status (SES), Naloxone Access Laws (NALs), and one-year lags were exploratory.
Results: Within-state regional intervals spanned zero (joint slope-equality p = 0.237); a separate common-slope estimate was 1.712 deaths per 100,000 per dispensing SD (95% CI −0.810 to 4.235). For the same random-intercept fit, the regional joint p value changed from < .001 under conventional inference to .269 under CR2. Matched GEE joint p values were .152 under independence and .033 under AR(1). SES and NAL estimates were uncertain; lagged associations did not identify causal direction.
Conclusions: Support for regional differences depended on how persistent state differences and correlation within states were handled, so these data do not give a consistent regional ranking. Curvature, negative fitted rates, and unmeasured confounding that changes over time further limit what these state aggregates can show.